IPOPLUS

₹1,156.9

▼ -17.65 -1.50%

16 Jun 2026

BSE Listed

Jenburkt Pharmaceuticals (524731)

Volume: 2,003Avg Vol 1W: 1,498Avg Vol 1M: 1,66152W Range:₹660.05₹1,375
BSE
Key Ratios
Updated 1h ago
Market Cap₹387 Cr
Current Price₹1,156.9
Previous Close₹1,174.55
High / Low (52w)₹1,375 / ₹660.05
Volume2,003
Avg Vol (1W)1,498
Avg Vol (1M)1,661
Stock P/E12.62
Book Value₹357.41
Dividend Yield—
ROE—
ROA—
Revenue (TTM)—
Revenue Growth—
Profit Margin—
Total Debt—
Shares Outstanding—
Face Value—
EPS (TTM)—
P/B2.42
Debt / Equity—
50 DMA₹1,110.53
200 DMA₹1,097.09
Day change-1.50%
Price Chart
₹1,156.9▼ 13.45% · 1Y
₹1393₹95529K
2025-06-18
2026-06-16

20-day avg volume: 2K shares

Pros
  • Revenue grew 11% YoY.
Quarterly Results
MetricMar 2026Dec 2025Jun 2025Mar 2025Dec 2024
Revenue₹45 Cr₹43 Cr₹36 Cr₹41 Cr₹37 Cr
EBITDA₹15 Cr₹9 Cr₹11 Cr₹13 Cr₹10 Cr
Net Profit₹11 Cr₹6 Cr₹8 Cr₹9 Cr₹7 Cr
EPS24.5813.4417.6619.3414.75
Profit & Loss (Annual)
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Revenue₹169 Cr₹152 Cr₹142 Cr₹136 Cr—
EBITDA₹50 Cr₹47 Cr₹38 Cr₹35 Cr—
Net Profit₹35 Cr₹32 Cr₹26 Cr₹25 Cr—
EPS—72.6558.8653.948.58
Balance Sheet
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Total Assets₹226 Cr₹196 Cr₹165 Cr₹142 Cr—
Total Liabilities₹29 Cr₹24 Cr₹20 Cr₹19 Cr—
Equity₹197 Cr₹172 Cr₹145 Cr₹122 Cr—
Total Debt₹2 Cr₹4 Cr₹0 Cr₹3 Cr—
Cash Flow
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Operating₹27 Cr₹28 Cr₹8 Cr₹17 Cr—
Investing₹-19 Cr₹-17 Cr₹-1 Cr₹3 Cr—
Financing₹-9 Cr₹-8 Cr₹-7 Cr₹-21 Cr—
Free Cash Flow₹13 Cr₹8 Cr₹6 Cr₹15 Cr—

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search